Literature DB >> 7224741

The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome.

H T Lynch, P M Lynch, J Pester, R M Fusaro.   

Abstract

Sebaceous neoplasia have been observed in members of four families exhibiting the cancer family syndrome (CFS). This disorder is characterized by adenocarcinomas, particularly involving the (proximal) colon, endometrium, and ovary; an excess of multiple primary cancer; early age of cancer onset; and autosomal dominant pattern of inheritance. Multiple adenomatous polyps are lacking in this disorder. In four patients from three of these cancer-prone kindreds, cutaneous lesions were accompanied by multiple visceral adenocarcinomas, fulfilling the criteria for Torre's syndrome, a disease that heretofore has not shown notable familial clustering characteristic of the CFS. Therefore, the coexistence of rare sebaceous neoplasia and visceral cancer in CFS supports the notion that some cases of Torre's syndrome may in fact represent the more full phenotypic expression of the gene responsible for the CFS.

Entities:  

Mesh:

Year:  1981        PMID: 7224741

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  34 in total

1.  An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation.

Authors:  Angela Arnold; Stewart Payne; Samantha Fisher; Diane Fricker; Judith Soloway; Susan M White; Marco Novelli; Kylie MacDonald; James Mackay; Richard Groves; Natalie Canham
Journal:  Fam Cancer       Date:  2007-02-24       Impact factor: 2.375

2.  [Recurrent eyelid tumors with different dignities].

Authors:  U Löw; C S L Müller; E Zemova; F A Flockerzi; B Seitz
Journal:  Ophthalmologe       Date:  2019-11       Impact factor: 1.059

3.  Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome.

Authors:  Anu R Lamba; Angela Y Moore; Todd Moore; Jennifer Rhees; Mildred A Arnold; C Richard Boland
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

4.  Lynch syndrome with exclusive skin involvement: time to consider a molecular definition?

Authors:  Alessandro Vaisfeld; Martina Calicchia; Maria Grazia Pomponi; Emanuela Lucci-Cordisco; Luca Reggiani-Bonetti; Maurizio Genuardi
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

Review 5.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

6.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

7.  First case report of Muir-Torre syndrome associated with non-small cell lung cancer.

Authors:  L Nolan; D Eccles; E Cross; G Crawford; N Beck; A Bateman; C Ottensmeier
Journal:  Fam Cancer       Date:  2009-05-16       Impact factor: 2.375

Review 8.  Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.

Authors:  Iyer Vishwas Neelakantan; Silvana Di Palma; C E T Smith; A McCoombe
Journal:  Head Neck Pathol       Date:  2015-11-17

9.  Ileocecal adenocarcinoma and ureteral transitional cell carcinoma with multiple sebaceous tumors and keratoacanthomas in a case of muir-torre syndrome.

Authors:  Michael C Lynch; Bryan E Anderson
Journal:  Dermatol Res Pract       Date:  2010-08-15

10.  Sebaceous gland adenoma of the palpebral conjunctiva in a patient with Muir-Torre-syndrome: a case report.

Authors:  F Meier-Gibbons; E Messmer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.